VERACYTE INC (VCYT) Fundamental Analysis & Valuation

NASDAQ:VCYT • US92337F1075

34.68 USD
-1.59 (-4.38%)
At close: Mar 5, 2026
33.9 USD
-0.78 (-2.25%)
Pre-Market: 3/6/2026, 8:55:07 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This VCYT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

7

Overall VCYT gets a fundamental rating of 7 out of 10. We evaluated VCYT against 520 industry peers in the Biotechnology industry. VCYT gets an excellent profitability rating and is at the same time showing great financial health properties. VCYT is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! This makes VCYT very considerable for growth and quality investing!


Dividend Valuation Growth Profitability Health

7

1. VCYT Profitability Analysis

1.1 Basic Checks

  • In the past year VCYT was profitable.
  • In the past year VCYT had a positive cash flow from operations.
  • In multiple years VCYT reported negative net income over the last 5 years.
  • VCYT had a positive operating cash flow in 4 of the past 5 years.
VCYT Yearly Net Income VS EBIT VS OCF VS FCFVCYT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M

1.2 Ratios

  • VCYT has a better Return On Assets (4.72%) than 90.96% of its industry peers.
  • With an excellent Return On Equity value of 5.07%, VCYT belongs to the best of the industry, outperforming 90.38% of the companies in the same industry.
  • With an excellent Return On Invested Capital value of 4.59%, VCYT belongs to the best of the industry, outperforming 90.96% of the companies in the same industry.
Industry RankSector Rank
ROA 4.72%
ROE 5.07%
ROIC 4.59%
ROA(3y)-0.03%
ROA(5y)-1.93%
ROE(3y)0%
ROE(5y)-2.06%
ROIC(3y)N/A
ROIC(5y)N/A
VCYT Yearly ROA, ROE, ROICVCYT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20 -40 -60 -80

1.3 Margins

  • VCYT's Profit Margin of 12.83% is amongst the best of the industry. VCYT outperforms 91.73% of its industry peers.
  • With an excellent Operating Margin value of 15.14%, VCYT belongs to the best of the industry, outperforming 92.31% of the companies in the same industry.
  • The Gross Margin of VCYT (70.10%) is better than 81.35% of its industry peers.
  • VCYT's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 15.14%
PM (TTM) 12.83%
GM 70.1%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.15%
GM growth 5Y1.62%
VCYT Yearly Profit, Operating, Gross MarginsVCYT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. VCYT Health Analysis

2.1 Basic Checks

  • VCYT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • VCYT has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for VCYT has been increased compared to 5 years ago.
  • There is no outstanding debt for VCYT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
VCYT Yearly Shares OutstandingVCYT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
VCYT Yearly Total Debt VS Total AssetsVCYT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B

2.2 Solvency

  • VCYT has an Altman-Z score of 17.69. This indicates that VCYT is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of VCYT (17.69) is better than 88.65% of its industry peers.
  • There is no outstanding debt for VCYT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 17.69
ROIC/WACC0.53
WACC8.73%
VCYT Yearly LT Debt VS Equity VS FCFVCYT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • VCYT has a Current Ratio of 8.15. This indicates that VCYT is financially healthy and has no problem in meeting its short term obligations.
  • VCYT has a Current ratio of 8.15. This is in the better half of the industry: VCYT outperforms 74.04% of its industry peers.
  • A Quick Ratio of 7.81 indicates that VCYT has no problem at all paying its short term obligations.
  • The Quick ratio of VCYT (7.81) is better than 72.69% of its industry peers.
Industry RankSector Rank
Current Ratio 8.15
Quick Ratio 7.81
VCYT Yearly Current Assets VS Current LiabilitesVCYT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. VCYT Growth Analysis

3.1 Past

  • VCYT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 176.67%, which is quite impressive.
  • The Revenue has grown by 16.01% in the past year. This is quite good.
  • The Revenue has been growing by 34.50% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)176.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%750%
Revenue 1Y (TTM)16.01%
Revenue growth 3Y20.37%
Revenue growth 5Y34.5%
Sales Q2Q%18.55%

3.2 Future

  • The Earnings Per Share is expected to grow by 21.22% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 10.74% on average over the next years. This is quite good.
EPS Next Y39.38%
EPS Next 2Y26.95%
EPS Next 3Y26.37%
EPS Next 5Y21.22%
Revenue Next Year12.64%
Revenue Next 2Y12.58%
Revenue Next 3Y12.06%
Revenue Next 5Y10.74%

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
VCYT Yearly Revenue VS EstimatesVCYT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M
VCYT Yearly EPS VS EstimatesVCYT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 1 -1 2

More info and screens

Find the best growth stocksShow best growing peers

6

4. VCYT Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 41.78, the valuation of VCYT can be described as expensive.
  • Based on the Price/Earnings ratio, VCYT is valued cheaply inside the industry as 90.58% of the companies are valued more expensively.
  • When comparing the Price/Earnings ratio of VCYT to the average of the S&P500 Index (26.69), we can say VCYT is valued expensively.
  • The Price/Forward Earnings ratio is 29.98, which means the current valuation is very expensive for VCYT.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of VCYT indicates a rather cheap valuation: VCYT is cheaper than 92.12% of the companies listed in the same industry.
  • VCYT's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 24.79.
Industry RankSector Rank
PE 41.78
Fwd PE 29.98
VCYT Price Earnings VS Forward Price EarningsVCYT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • VCYT's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. VCYT is cheaper than 93.08% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, VCYT is valued cheaper than 95.19% of the companies in the same industry.
Industry RankSector Rank
P/FCF 21.76
EV/EBITDA 22.99
VCYT Per share dataVCYT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • VCYT's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • VCYT has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as VCYT's earnings are expected to grow with 26.37% in the coming years.
PEG (NY)1.06
PEG (5Y)N/A
EPS Next 2Y26.95%
EPS Next 3Y26.37%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. VCYT Dividend Analysis

5.1 Amount

  • VCYT does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

VCYT Fundamentals: All Metrics, Ratios and Statistics

VERACYTE INC

NASDAQ:VCYT (3/5/2026, 8:25:24 PM)

Premarket: 33.9 -0.78 (-2.25%)

34.68

-1.59 (-4.38%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-25
Earnings (Next)05-05
Inst Owners114.83%
Inst Owner Change-4.94%
Ins Owners0.42%
Ins Owner Change-3.94%
Market Cap2.76B
Revenue(TTM)517.14M
Net Income(TTM)66.35M
Analysts82.11
Price Target50.17 (44.67%)
Short Float %7.67%
Short Ratio7.52
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)105.79%
Min EPS beat(2)79.03%
Max EPS beat(2)132.56%
EPS beat(4)3
Avg EPS beat(4)43.36%
Min EPS beat(4)-110.32%
Max EPS beat(4)132.56%
EPS beat(8)6
Avg EPS beat(8)164.25%
EPS beat(12)8
Avg EPS beat(12)72.71%
EPS beat(16)12
Avg EPS beat(16)65.75%
Revenue beat(2)2
Avg Revenue beat(2)3.25%
Min Revenue beat(2)3.19%
Max Revenue beat(2)3.31%
Revenue beat(4)4
Avg Revenue beat(4)3.32%
Min Revenue beat(4)1.01%
Max Revenue beat(4)5.76%
Revenue beat(8)7
Avg Revenue beat(8)3.84%
Revenue beat(12)11
Avg Revenue beat(12)4.44%
Revenue beat(16)15
Avg Revenue beat(16)5.09%
PT rev (1m)0.93%
PT rev (3m)4.04%
EPS NQ rev (1m)-10.56%
EPS NQ rev (3m)-25.47%
EPS NY rev (1m)5.61%
EPS NY rev (3m)33.75%
Revenue NQ rev (1m)0.27%
Revenue NQ rev (3m)0.17%
Revenue NY rev (1m)0.14%
Revenue NY rev (3m)3.19%
Valuation
Industry RankSector Rank
PE 41.78
Fwd PE 29.98
P/S 5.33
P/FCF 21.76
P/OCF 20.22
P/B 2.1
P/tB 6.08
EV/EBITDA 22.99
EPS(TTM)0.83
EY2.39%
EPS(NY)1.16
Fwd EY3.34%
FCF(TTM)1.59
FCFY4.6%
OCF(TTM)1.72
OCFY4.95%
SpS6.51
BVpS16.48
TBVpS5.7
PEG (NY)1.06
PEG (5Y)N/A
Graham Number17.54
Profitability
Industry RankSector Rank
ROA 4.72%
ROE 5.07%
ROCE 5.82%
ROIC 4.59%
ROICexc 6.63%
ROICexgc 80.43%
OM 15.14%
PM (TTM) 12.83%
GM 70.1%
FCFM 24.49%
ROA(3y)-0.03%
ROA(5y)-1.93%
ROE(3y)0%
ROE(5y)-2.06%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.15%
GM growth 5Y1.62%
F-Score8
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 45.19%
Cap/Sales 1.87%
Interest Coverage 250
Cash Conversion 136.72%
Profit Quality 190.84%
Current Ratio 8.15
Quick Ratio 7.81
Altman-Z 17.69
F-Score8
WACC8.73%
ROIC/WACC0.53
Cap/Depr(3y)43.31%
Cap/Depr(5y)38.08%
Cap/Sales(3y)2.39%
Cap/Sales(5y)2.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)176.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%750%
EPS Next Y39.38%
EPS Next 2Y26.95%
EPS Next 3Y26.37%
EPS Next 5Y21.22%
Revenue 1Y (TTM)16.01%
Revenue growth 3Y20.37%
Revenue growth 5Y34.5%
Sales Q2Q%18.55%
Revenue Next Year12.64%
Revenue Next 2Y12.58%
Revenue Next 3Y12.06%
Revenue Next 5Y10.74%
EBIT growth 1Y301.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year205.84%
EBIT Next 3Y58.94%
EBIT Next 5Y37.52%
FCF growth 1Y98.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y81.51%
OCF growth 3Y162.45%
OCF growth 5YN/A

VERACYTE INC / VCYT FAQ

What is the fundamental rating for VCYT stock?

ChartMill assigns a fundamental rating of 7 / 10 to VCYT.


What is the valuation status of VERACYTE INC (VCYT) stock?

ChartMill assigns a valuation rating of 6 / 10 to VERACYTE INC (VCYT). This can be considered as Fairly Valued.


How profitable is VERACYTE INC (VCYT) stock?

VERACYTE INC (VCYT) has a profitability rating of 7 / 10.


Can you provide the PE and PB ratios for VCYT stock?

The Price/Earnings (PE) ratio for VERACYTE INC (VCYT) is 41.78 and the Price/Book (PB) ratio is 2.1.


What is the financial health of VERACYTE INC (VCYT) stock?

The financial health rating of VERACYTE INC (VCYT) is 8 / 10.